Resilience Amid Challenges

The growth,scale and scope of the novel coronavirus outbreak in China has be-come one of the most talked about global subjects.The virus is first and foremost a domes-tic health issue for China,with an increasing international potential.President Xi Jinping is leading a national effort to contain the outbreak while scientists and doctors in China and around the world are working to find a vaccine and/or cure.     

THIS WEEK

正A STRONGER DEFENSE A medical worker administers a COVID-19 vaccine booster shot to a man at an inoculation site in Guangzhou, Guangdong Province, on October 18. China has begun offering booster vaccines to residents aged 18 and above, who have been fully vaccinated with inactivated vaccines or the one-dose adenovirus vector vaccine for six months.     

THIS WEEK SOCIETY

Vacci ne Developme nt The COVID-19 vaccine workshop of the China National Pharmaceutical Group(Sinopharm)on April 10.Developed by the Wuhan Institute of Biological Products under Sinopharm and the Wuhan Institute of Virology under the Chinese Academy of Sciences,the vaccine was approved for clinical trial on April 12 An other vaccine developed by Sinovac Research and Development,a company based in Beijing,was approved for trial on April 13.     

Toward Vaccine Equity

Policies must ensure accessibility and affordability for all Though COVID-19 triggered an exceptional crisis with unforeseen and shifting challenges, vaccine manufacturing and supply has seen unprecedented progress worldwide in less than a year.     

Focus

China Completes Phase-I Clinical Trials on First AIDS Vaccine The rst AIDS vaccine developed by Chinese scientists has completed its phase-1 clini- cal trials. The results show it to be safe and e ective. None of the 49 healthy volunteers exhibited negative reactions to the vaccine over a 180-day period of observation, and appeared immune to the HIV virus 15 days after injection. The participants were 33 men and 16 women aged between 18 and 50, divided into eight groups. A total of 344…     

TOP 10 WORLD NEWS STORIES OF 2021

COVID-19 Pandemic New COVID-19 variants such as Delta and Omicron flooded the world throughout the year,sparking significantly higher infection rates.Since the first reported infections in December 2019,the world has seen over 280 million confirmed cases,including over 5.4 million deaths,and the administration of over 8 billion vaccine doses,according to the World Health Organization.     

A Vaccine for All

正China and the United States are leading the rest of the world in the efforts to develop a vaccine for the novel coronavirus disease (COVID-19). Scientists around the world are working on more than 120 vaccines, while 11 have been approved for clinical trial so far.Of these 11 vaccines, five come from scientists in China and four from the U.S.     

PEOPLE & POINTS

正TOP EPIDEMIOLOGIST’S VACCINE BREAKTHROUGH Chen Wei, an academician at the People’s Liberation Army (PLA) Academy of Military Medical Sciences, has made critical progress in developing a novel coronavirus vaccine with the support of her research team.The military medical expert team has been working in Wuhan in central China for     

THIS WEEK

Beijing Review has undergone a redesign for 2012,creating a fresh look for readers of the magazine that has informed domestic and international audiences about China for over five decades. We warmly encourage readers to interact with our editors and reporters via the e-mail addresses provided in each edition and offer more crucial feedback to help the quality of articles and the diversity of opinions and viewpoints.     

Why China Can't Back Down In the Donglang Standoff

正The military standoff between China and India in the Donglang region has lasted for almost two months by far,and there is still no end in sight.China has made it clear that there is no room for negotiation and the only solution is the unconditional and immediate withdrawal of Indian troops from the region.